Vimarsana
Biggest News Aggregation in the World

Sol Gel Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sol Gel Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sol Gel Technologies Today - Breaking & Trending Today

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Up 107.1% in May - Vimarsana News

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Up 107.1% in May

Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 20,500 shares, a growth of 107.1% from the May 15th total of 9,900 shares. Based on an average trading volume of 32,500 shares, […]

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Forecasted to Post Q1 2025 Earnings of ($0.21) Per Share - Vimarsana News

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Forecasted to Post Q1 2025 Earnings of ($0.21) Per Share

Sol-Gel Technologies Ltd. (NASDAQ:SLGL – Free Report) – Stock analysts at HC Wainwright issued their Q1 2025 earnings estimates for Sol-Gel Technologies in a research report issued on Monday, May 20th. HC Wainwright analyst R. Selvaraju forecasts that the company will post earnings per share of ($0.21) for the quarter. HC Wainwright has a “Buy” […]

Sol-Gel Reports First Quarter 2024 Financial Results And Provides Corporate Updates - Vimarsana News

Sol-Gel Reports First Quarter 2024 Financial Results And Provides Corporate Updates

Source: menafn.com
Transplant Recipients: Consider Skin Cancer, Infection Risks - Vimarsana News

Transplant Recipients: Consider Skin Cancer, Infection Risks

Recent research sheds light on varying skin cancer risk, and a predictive tool offers guidance on screening in solid organ transplant recipients.

2024-04-01 | NDAQ:SLGL | Press Release | Sol Gel Technologies Ltd - Vimarsana News

2024-04-01 | NDAQ:SLGL | Press Release | Sol Gel Technologies Ltd

(2024-04-01 | NDAQ:SLGL) Sol-Gel's Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream